Related Experiment Videos
[Fulminant hepatitis in children. Treatment by exchange transfusion]
Insights
Fulminant hepatitis in children can be fatal. Exchange transfusion showed a lower mortality rate (91%) compared to conservative treatment (100%), but further studies are needed for evaluation.
Area of Science:
- Hepatology
- Pediatric Infectious Diseases
- Critical Care Medicine
Context:
- Fulminant hepatitis presents a severe, life-threatening clinical manifestation of viral hepatitis.
- This study examines clinical experience with pediatric patients suffering from severe hepatitis.
- The Infectious Disease Hospital of the I.M.S.S. in Mexico City served as the study site.
Purpose:
- To evaluate the efficacy of exchange transfusion in managing severe pediatric fulminant hepatitis.
- To compare outcomes between children treated with exchange transfusion and a conservatively managed control group.
- To review existing literature on exchange transfusion for fulminant hepatitis.
Summary:
- Twenty-two pediatric patients with grade III or IV encephalopathy due to fulminant hepatitis underwent exchange transfusion.
- The mortality rate in the exchange transfusion group was 91%, compared to 100% in the conservative treatment control group.
- Literature review revealed significant variability in reported outcomes for exchange transfusion, highlighting the need for further research.
Impact:
- The findings suggest a potential benefit of exchange transfusion in reducing mortality for severe pediatric fulminant hepatitis.
- This study underscores the critical need for well-controlled, prospective research to definitively establish the effectiveness of exchange transfusion.
- Results may inform clinical decision-making and future research protocols in managing pediatric fulminant hepatitis.
Abstract:
Fulminant hepatitis is a potentially fatal clinical form of viral hepatitis. The experience at the Infectious Disease Hospital of the I.M.S.S. in Mexico City is presented. Twenty-two children with encephalopathy, grade III or IV managed with exchange transfusion were included. Results between these patients and a similar control group treated conservatively were compared. The mortality rates for the exchange transfusion and the control group were 91 and 100% respectively. A review of the literature revaled great differences in results obtained by several other authors. We conclude that well controled, prospective studies should be done, before the true efficiency of exchange transfusion can be properly evaluated.